TANDEM trial

Study / Research

A trial combining Obicetrapib with Ezetimibe, resulting in approximately 50% LDL lowering.

Mentioned in 1 video

Videos Mentioning TANDEM trial

407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more

407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more

Peter Attia MD

A trial combining Obicetrapib with Ezetimibe, resulting in approximately 50% LDL lowering.